KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance

被引:0
作者
Song Zheng
Ke-er Huang
Yue-long Pan
Yao Zhou
Song-dan Pan
Xin Li
Jing Jia
Xiao-liang Zheng
De-you Tao
机构
[1] The First People’s Hospital of Hangzhou,Department of Oncology, Hangzhou Cancer Hospital
[2] Zhejiang University,Department of Emergency, Second Affiliated Hospital, School of Medicine
[3] Zhejiang Academy of Medical Sciences,Department of Oncology
[4] Taizhou Hospital of Zhejiang Province,undefined
来源
Gastric Cancer | 2015年 / 18卷
关键词
Gastrointestinal stromal tumor; KIT; BRAF; Rhabdomyosarcomatous differentiation; Imatinib resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:796 / 802
页数:6
相关论文
共 146 条
[1]  
Gomes AL(2007)Molecular analysis of c-KIT and PDGFR in GISTs diagnosed by EUS Am J Clin Pathol 127 89-96
[2]  
Bardales RH(2003)PDGFR activating mutations in gastrointestinal stromal tumors Science 299 708-710
[3]  
Milanezi F(2007)Mutations in gastrointestinal stromal tumors: a population-based study from northern Norway APMIS 115 289-298
[4]  
Reis RM(2002)Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors Clin Cancer Res 8 3034-3038
[5]  
Schmitt F(2007) mutations and imatinib dose effects in patients with gastrointestinal stromal tumors (letter) J Clin Oncol 25 1146-1147
[6]  
Heinrich MC(2004)Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs) Oncogene 13 3999-4006
[7]  
Corless CL(2003)Signal transduction by several KIT juxtamembrane domain mutations Oncogene 22 4710-4722
[8]  
Duensing A(2006)Raf kinases: oncogenesis and drug discovery Int J Cancer 119 2261-2271
[9]  
McGreevey L(2002)Mutations of the Nature 417 949-954
[10]  
Chen CJ(2008) gene in human cancer Genes Chromosomes Cancer 47 853-859